Air pollution has traditionally been regarded as an external environmental concern, primarily threatening respiratory health. However, burgeoning research is now illuminating its detrimental effects on brain health. Fine particulate matter, or PM2.5, is a particularly insidious form of air pollution composed of tiny particles that can be deeply inhaled into the lungs and even absorbed into the bloodstream. Historically, the focus has been on the immediate physical impacts of PM2.5, such as tissue damage and lung inflammation. Only recently has the spotlight shifted to its potential implications for cognitive decline, an area that is just beginning to be understood.
A pivotal study conducted by researchers from Rostock, Bonn, and Luxembourg universities has shed light on a potential mechanism linking air pollution to cognitive impairment: systemic inflammation. This inflammation, spurred by an increase in monocytes — a type of white blood cell — may play a critical role in how PM2.5 contributes to the deterioration of cognitive functions. Their findings have been published in the esteemed scientific journal Alzheimer’s & Dementia, marking a significant advancement in our understanding of this issue.
PM2.5 particles are minuscule enough to bypass the body’s primary air filters and enter the lungs and bloodstream, posing substantial health threats. Long-standing exposure to these particles has been associated with an increased risk of developing neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Recent reports by the Lancet Commission on dementia prevention, intervention, and care have even listed air pollution as a modifiable risk factor, highlighting the urgent need for more comprehensive understanding and intervention strategies. Despite the growing recognition of these risks, the specific biological mechanisms by which PM2.5 affects cognitive functions remain largely unexplored.
The breadth of research on cognitive decline has predominantly concentrated on older populations, but current studies are expanding this focus to include the effects on younger adults. Evidence suggests that even chronic low-level exposure to PM2.5 during early and mid-life may influence long-term cognitive outcomes. In exploring this, the research team analysed data from over 66,000 participants in the Dutch Lifelines cohort. By correlating participants’ blood analyses and cognitive test results over a decade with air pollution data from their residential locations gathered through the ELAPSE project, researchers have begun to uncover the complex mechanisms at play.
The study identified a correlation between PM2.5 exposure and a decline in cognitive processing time (CPT), which reflects the brain’s speed in responding to stimuli. A noteworthy aspect of their findings is the significant role of an increased white blood cell count, mainly monocytes, in mediating this effect. According to Dr Benjamin Aretz, a research scientist at the University Hospital Bonn and the study’s first author, systemic inflammation may be a crucial intermediary connecting PM2.5 exposure to cognitive impairments. This marks the first large-scale study to directly associate changes in white blood cell count with the cognitive effects of delicate particulate matter.
While it’s known that PM2.5 can directly impact the brain by crossing the blood-brain barrier and inducing local inflammation, this study accentuates the broader systemic inflammation that occurs upon exposure. Prof. Gabriele Doblhammer, group leader at the DZNE in Rostock, hypothesised that pollutants might trigger an increase in white blood cells, disrupting immune functions in the brain and contributing to cognitive decline. The role of inflammation in the onset of neurodegenerative diseases is well-documented, making it a critical area of study for understanding how air pollution impacts cognitive health.
In an era marked by increasing urbanisation and an ageing population, comprehending and mitigating the effects of air pollution on neurodegenerative diseases is becoming increasingly critical. Prof. Michael Heneka, director of the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg and senior author of the study, stresses the importance of further research to identify specific pollutants and their cellular mechanisms that mediate cognitive impairment. Insights from such studies could significantly influence public health policies to reduce the risks associated with long-term exposure to PM2.5, ultimately protecting brain health on a broader scale.
More information: Benjamin Aretz et al, The role of leukocytes in cognitive impairment due to long-term exposure to fine particulate matter: A large population-based mediation analysis, Alzheimer’s & Dementia. DOI: 10.1002/alz.14320
Journal information: Alzheimer’s & Dementia Provided by University of Luxembourg
